Invesaro

Stocks Comparison

BGC vs Cme: revenue, profit, margins and growth compared

BGC brought in $2.9B of revenue in fiscal 2025, Cme $6.5B in fiscal 2025. Revenue changed by +30.0% at BGC and +6.4% at Cme on the year before, so BGC grew faster. BGC kept 5.3% of its revenue as net profit, Cme 62.5%. Free cash flow was $372.9M at BGC and $4.2B at Cme.

Side by side, latest fiscal year

BGCCME
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.9B$6.5B
Revenue growth+30.0%+6.4%
Net income$155M$4.1B
Net margin5.3%62.5%
Free cash flow$372.9M$4.2B
Free cash flow margin12.7%64.3%
Earnings per share (diluted)$0.31$11.16
Cash$851.5M$4.4B
Debt$1.5Bn/a
Price to earnings38.223.7
Market value$5.6B$95.1B
Dividend yield0.68%1.89%
Rank by revenue in sector#123 of 444 · Finance#84 of 444 · Finance

Over the years

Revenue
BGC FY2018: $1.9BBGC FY2019: $2.1BBGC FY2020: $2.1BBGC FY2021: $2BBGC FY2022: $1.8BBGC FY2023: $2BBGC FY2024: $2.3BBGC FY2025: $2.9BCME FY2018: $4.3BCME FY2019: $4.9BCME FY2020: $4.9BCME FY2021: $4.7BCME FY2022: $5BCME FY2023: $5.6BCME FY2024: $6.1BCME FY2025: $6.5BFY18FY19FY20FY21FY22FY23FY24FY25
BGC $2.9BCME $6.5B
Net income
BGC FY2018: $202.2MBGC FY2019: $43.9MBGC FY2020: $50.9MBGC FY2021: $153.5MBGC FY2022: $58.9MBGC FY2023: $38.8MBGC FY2024: $123.2MBGC FY2025: $155MCME FY2018: $2BCME FY2019: $2.1BCME FY2020: $2.1BCME FY2021: $2.6BCME FY2022: $2.7BCME FY2023: $3.2BCME FY2024: $3.5BCME FY2025: $4.1BFY18FY19FY20FY21FY22FY23FY24FY25
BGC $155MCME $4.1B
Net margin
BGC FY2018: 10.4%BGC FY2019: 2.1%BGC FY2020: 2.5%BGC FY2021: 7.6%BGC FY2022: 3.3%BGC FY2023: 1.9%BGC FY2024: 5.4%BGC FY2025: 5.3%CME FY2018: 45.5%CME FY2019: 43.5%CME FY2020: 43.1%CME FY2021: 56.2%CME FY2022: 53.6%CME FY2023: 57.8%CME FY2024: 57.5%CME FY2025: 62.5%FY18FY19FY20FY21FY22FY23FY24FY25
BGC 5.3%CME 62.5%
Revenue growth
BGC FY2019: +8.6%BGC FY2020: -2.3%BGC FY2021: -2.0%BGC FY2022: -10.9%BGC FY2023: +12.8%BGC FY2024: +11.7%BGC FY2025: +30.0%CME FY2019: +13.0%CME FY2020: +0.3%CME FY2021: -4.0%CME FY2022: +7.0%CME FY2023: +11.1%CME FY2024: +9.9%CME FY2025: +6.4%FY19FY20FY21FY22FY23FY24FY25
BGC +30.0%CME +6.4%
Free cash flow
BGC FY2018: -$91.9MBGC FY2019: $194.4MBGC FY2020: $271.8MBGC FY2021: $407.1MBGC FY2022: $213.8MBGC FY2023: $390.3MBGC FY2024: $285.7MBGC FY2025: $372.9MCME FY2018: $2.3BCME FY2019: $2.4BCME FY2020: $2.5BCME FY2021: $2.3BCME FY2022: $3BCME FY2023: $3.4BCME FY2024: $3.6BCME FY2025: $4.2BFY18FY19FY20FY21FY22FY23FY24FY25
BGC $372.9MCME $4.2B

Fiscal years as each company reports them; the two may end in different months.

Questions about BGC and Cme

Which is bigger by revenue, BGC or Cme?

Cme is bigger by revenue: $6.5B in fiscal 2025, against $2.9B for BGC in fiscal 2025.

Which keeps more of its revenue as profit, BGC or Cme?

BGC had a net margin of 5.3% in fiscal 2025; Cme had 62.5% in fiscal 2025.

Which grew revenue faster, BGC or Cme?

In their latest fiscal years revenue changed by +30.0% at BGC and +6.4% at Cme.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies